These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1970264)

  • 1. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and the renal response to gludopa, fenoldopam and dopamine.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Oct; 30(4):652-3. PubMed ID: 1981323
    [No Abstract]   [Full Text] [Related]  

  • 3. Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.
    Schoors DF; Dupont AG
    Br J Clin Pharmacol; 1990 Oct; 30(4):651-2. PubMed ID: 1981322
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
    Ragsdale NV; Lynd M; Chevalier RL; Felder RA; Peach MJ; Carey RM
    Hypertension; 1990 Jun; 15(6 Pt 2):914-21. PubMed ID: 1972140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K; Felder RA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
    Polak MJ; Kennedy LA; Drummond WH
    Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion.
    Bass AS; Murphy MB
    Clin Exp Hypertens A; 1991; 13(6-7):1127-51. PubMed ID: 1684742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.